DNA topoisomerase-targeting chemotherapeutics: what's new?

Cancer Chemotherapy and Pharmacology
Selma M CuyaRobert C A M van Waardenburg

Abstract

To resolve the topological problems that threaten the function and structural integrity of nuclear and mitochondrial genomes and RNA molecules, human cells encode six different DNA topoisomerases including type IB enzymes (TOP1 and TOP1mt), type IIA enzymes (TOP2α and TOP2β) and type IA enzymes (TOP3α and TOP3β). DNA entanglements and the supercoiling of DNA molecules are regulated by topoisomerases through the introduction of transient enzyme-linked DNA breaks. The covalent topoisomerase-DNA complexes are the cellular targets of a diverse group of cancer chemotherapeutics, which reversibly stabilize these reaction intermediates. Here we review the structure-function and catalytic mechanisms of each family of eukaryotic DNA topoisomerases and the topoisomerase-targeting agents currently approved for patient therapy or in clinical trials, and highlight novel developments and challenges in the clinical development of these agents.

References

Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·M GellertH A Nash
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T D ChungC K Mirabelli
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J Nitiss, J C Wang
Jan 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·J J Champoux, R Dulbecco
Feb 14, 1971·Journal of Molecular Biology·J C Wang
Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·K MizuuchiM Gellert
Jan 1, 1982·The American Journal of Medicine·N J VogelzangB J Kennedy
Jan 18, 1996·Nature·J M BergerJ C Wang
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·R HanaiJ C Wang
Jun 13, 1997·Journal of Molecular Biology·L StewartJ J Champoux
Apr 1, 1996·Journal of Ethnopharmacology·M E Wall, M C Wani
Mar 21, 1998·Science·L StewartJ J Champoux
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K R Hande
Jul 3, 1999·Nucleic Acids Research·B S ParkerD R Phillips
Mar 4, 2000·Progress in Nucleic Acid Research and Molecular Biology·J M Fortune, N Osheroff
Aug 15, 2000·The Journal of Biological Chemistry·M P BolandL A O'Neill
Feb 24, 2001·Annals of the New York Academy of Sciences·O LavergneD C Bigg
Feb 24, 2001·Annals of the New York Academy of Sciences·E BovenH M Pinedo
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·T K Li, L F Liu
Jun 8, 2001·Annual Review of Biochemistry·J J Champoux
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·H ZhangY Pommier
May 15, 2002·Trends in Pharmacological Sciences·James J Champoux
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·James C Wang
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Annemarie H Van HattumEpie Boven
Sep 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yong WangJames C Wang
Oct 9, 2002·Current Pharmaceutical Design·Franco ZuninoGraziella Pratesi
Nov 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bart L StakerLance Stewart
Nov 22, 2002·The Journal of Biological Chemistry·Héctor VillaDavid Ordóñez
Jul 31, 2003·Pharmacology & Therapeutics·Annette K LarsenAndrzej Skladanowski
Mar 10, 2004·Biochemical Pharmacology·Anna Cleta CroceFranco Zunino
Apr 21, 2004·Nucleic Acids Research·Hongliang ZhangYves Pommier
Oct 20, 2004·Cancer Research·Clinton F StewartPeter J Houghton
Apr 15, 2005·Chromosoma·John B Leppard, James J Champoux
Jul 8, 2005·Cancer Chemotherapy and Pharmacology·David J AdamsMansukh C Wani
Aug 16, 2005·The Journal of Biological Chemistry·Hua WeiGregory L Verdine

❮ Previous
Next ❯

Citations

May 23, 2018·Future Medicinal Chemistry·Mohamed A AbdelsalamMahmoud M Elaasser
Oct 28, 2017·The Journal of Biological Chemistry·Joyce H LeeJames M Berger
Jun 1, 2019·Expert Review of Anticancer Therapy·Robin Van Den BorgGodefridus J Peters
Apr 2, 2019·Current Topics in Medicinal Chemistry·Wenjie Wang, Yuk-Ching Tse-Dinh
Oct 12, 2019·F1000Research·Mary-Ann Bjornsti, Scott H Kaufmann
Nov 28, 2019·Oxidative Medicine and Cellular Longevity·Cristiano TrindadeJoão A P Henriques
Oct 9, 2020·Cancers·Caroline MolinaroKatia Cailliau
Sep 26, 2020·Journal of Enzyme Inhibition and Medicinal Chemistry·Kamila BuzunAgnieszka Gornowicz
Dec 17, 2020·International Journal of Molecular Sciences·Dusana Majera, Martin Mistrik
Jun 1, 2021·Frontiers in Cell and Developmental Biology·Héllida Marina Costa-SilvaCarlos Renato Machado
Jun 3, 2021·Cancers·Radka MichalkovaJan Mojzis
Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Adam J BuricDanzhou Yang
May 16, 2019·ACS Chemical Biology·Emilia KomulainenKeith W Caldecott
Sep 14, 2021·Journal of Applied Toxicology : JAT·Maria Kozurkova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.